AVXL insider transaction filings
ANAVEX LIFE SCIENCES CORP. — 32 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-01-09. Screen AVXL transaction legs live →
Insider transaction summary — last 90 days
No Form 4 filings for AVXL between 2026-06-24 and 2026-09-22. The table below lists the most recent filings on record.
Recent Form 4 filings — ANAVEX LIFE SCIENCES CORP.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-01-09 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-10-03 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-09-12 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 187,500 @ $5.04 · Tax withholding (F): 145,048 @ $9.58 · Option exercise (M): 187,500 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-06-09 | 4 | Thomas Steffen — Director | Option exercise (M): 50,000 @ $1.76 · Tax withholding (F): 11,349 @ $7.75 · Option exercise (M): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-04-30 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Donhauser Peter D.O. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Ma Jiong — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Skarpelos Athanasios — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Thomas Steffen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | Velden Claus Vander — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2025-03-26 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 500,000 @ $0.92 · Tax withholding (F): 282,497 @ $9.63 · Option exercise (M): 500,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 166,666 (derivative) @ $0 · Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 12,500 (derivative) @ $0 | EDGAR |
| 2024-12-23 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-12-06 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | Donhauser Peter D.O. — Director | Purchase (P): 2,835 @ $3.64 | EDGAR |
| 2024-05-17 | 4 | Thomas Steffen — Director | Purchase (P): 5,000 @ $4.52 | EDGAR |
| 2024-04-01 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Option exercise (M): 73,380 @ $1.32 · Sale (S): 73,380 @ $5.11 · Option exercise (M): 73,380 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Donhauser Peter D.O. — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Velden Claus Vander — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Thomas Steffen — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Ma Jiong — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-02-23 | 4 | Skarpelos Athanasios — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Boenisch Sandra — PFO & Treasurer | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | MISSLING CHRISTOPHER U — President and CEO, Director | Grant/award (A): 125,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — ANAVEX LIFE SCIENCES CORP.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-09 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-17 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-03 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-20 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-06-26 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=AVXL returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →